FDA Inspection 1046031 — Agios Pharmaceuticals, INC.
The FDA completed an inspection of Agios Pharmaceuticals, INC. on Mar 9, 2018 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 9, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge, MA (United States)
Additional Details
Sponsor, Contract Research Organization